ClinicalTrials.Veeva

Menu

Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer

LG Chem logo

LG Chem

Status

Completed

Conditions

Infertility, Female

Treatments

Drug: rFSH

Study type

Observational

Funder types

Industry

Identifiers

NCT05130125
LG-IMHOS001

Details and patient eligibility

About

A multicenter, retrospective cohort observational study to evaluate the effectiveness and safety of fresh or frozen embryo transfer after ovarian hyperstimulation (administration of rFSH or HP-hMG alone or co-administration of rFSH and HP-hMG)

Full description

A multicenter, retrospective cohort observational study to evaluate the effectiveness and safety of fresh or frozen embryo transfer after ovarian hyperstimulation (administration of rFSH or HP-hMG alone or co-administration of rFSH and HP-hMG) to infertile female patients undergoing assisted reproductive technology to controlled ovarian hyperstimulation

Enrollment

1,166 patients

Sex

Female

Ages

19 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First IVF-ET cycle patients

Exclusion criteria

Poor ovarian responder

  • At least two of the following three features must be present: (i) Advanced maternal age (≥ 40 years) or any other risk factor for Poor ovarian response (POR); (ii) A previous POR (≤ 3 oocytes with a conventional stimulation protocol); (iii) An abnormal ovarian reserve test (i.e. AFC < 5-7 follicles or AMH < 0.5-1.1 ng/mL)

Trial design

1,166 participants in 2 patient groups

fresh embryo
Description:
fresh embryo transfer after ovarian hyperstimulation
Treatment:
Drug: rFSH
frozen embryo
Description:
frozen embryo transfer after ovarian hyperstimulation
Treatment:
Drug: rFSH

Trial contacts and locations

1

Loading...

Central trial contact

Yujung Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems